Multivariate analyses further demonstrated that EIF5A2 was an independent adverse prognostic marker of OS (P = 0.041), FFS (P = 0.029), and D-FFS (P = 0.043) in NPC patients. The gene discussed is EIF5A2; the disease is nasopharyngeal carcinoma.